Treating Psychosis in Parkinson's Patients a Delicate Balancing Act for Physicians

Video

Patients diagnosed with Parkinson's disease face a wide range of physical ailments with their condition. One of the lesser addressed areas is the psychological aspects they face as well. Therapeutic alternatives are being developed to help treat psychosis in this particular patient group.

Patients diagnosed with Parkinson's disease face a wide range of physical ailments with their condition. One of the lesser addressed areas is the psychological aspects they face as well. Therapeutic alternatives are being developed to help treat psychosis in this particular patient group.

Jeffrey Cummings, MD, from the Cleveland Clinic discussed the effort to raise awareness about these two conditions during the American Academy of Neurology's annual meeting in Washington DC. Cummings said close to 50% of Parkinson's disease patients will "develop some psychotic phenomenon." In addition to the affect it has on the patient, Cummings said it also increases the burden on the patient's caregiver.

Related Videos
The Future of DSM-5-TR with APA Members Nitin Gogtay, Maria Oquendo, Jonathan Alpert
Ashkan Abbey, MD: 3-Year Efficacy of Pegcetacoplan for Geographic Atrophy | Image Credit: Texas Retina AssociatesImage Credit:
Paul Appelbaum, MD: What to Warn Patients When Prescribing Psychedelics in the Future
Clozapine and Second-Generation Antipsychotics for Schizophrenia, with John Kane, MD
Ryan McLaughlin, PhD: Challenges Studying Cannabis to Treat Psychiatric Illness
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
Charles R. Marmar, MD: Blood Biomarkers for PTSD
John Kane, MD: Shifts in Antipsychotics for Schizophrenia
Andrew Chen, MD: Taking More Adverse Event Prone Anxiety Medications
© 2024 MJH Life Sciences

All rights reserved.